Venous endothelin receptor function in patients with chronic heart failure

Love, M. P., Haynes, W. G., Webb, D. J. and McMurray, J. J.V. (2000) Venous endothelin receptor function in patients with chronic heart failure. Clinical Science, 98(1), pp. 65-70. (doi: 10.1042/cs19990174) (PMID:10600660)

Full text not currently available from Enlighten.

Abstract

Cardiac preload reduction through venodilatation is beneficial in chronic heart failure. The recent development of endothelin receptor antagonists for possible therapeutic use in heart failure has hastened the need for a clearer understanding of the venoconstrictor actions of endothelin-1 in this disease. Two main subtypes of endothelin receptor, ETA and ETB, exist in human blood vessels. We studied the venoconstrictor effects of endothelin-1 (a non-selective ETA and ETB agonist) and sarafotoxin S6c (a selective ETB agonist) in vivo in patients with chronic heart failure and in age-matched healthy controls. On separate days at least 1 week apart, locally active doses of endothelin-1 or sarafotoxin S6c were infused into a suitable dorsal hand vein for 1 h, and the venous internal diameter was measured using a displacement technique. Venoconstriction in response to endothelin-1 was significantly blunted in heart failure patients compared with controls (26±7% and 51±6% peak reduction in vein calibre respectively; P = 0.013). Venoconstriction to sarafotoxin S6c was similar in heart failure patients and controls (17±5% and 17±4% peak reduction in vein calibre respectively). Both ETA and ETB receptors mediate venoconstriction in healthy subjects and in patients with chronic heart failure. Optimal inhibition of the venoconstrictor effects of endothelin-1 in chronic heart failure may therefore require administration of an antagonist with ETA- and ETB-receptor-blocking properties. Chronic heart failure may be associated with a selective decrease in venous ETA receptor sensitivity, but further studies are required to clarify the functional significance of this observation.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:McMurray, Professor John
Authors: Love, M. P., Haynes, W. G., Webb, D. J., and McMurray, J. J.V.
College/School:College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health
Journal Name:Clinical Science
Publisher:Portland Press Ltd.
ISSN:0143-5221
ISSN (Online):1470-8736

University Staff: Request a correction | Enlighten Editors: Update this record